A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic, were linked to a 33% lower risk of ...

A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic and Wegovy, were linked to a 33% ...

GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite ...

Donanemab, approved by the FDA in 2024 to treat Alzheimer's disease, is a monoclonal antibody directed at N-terminally ...

Opening Minds through Art (OMA) is an award-winning, evidence-based program. It’s an opportunity for creative self-expression ...

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...

Six months ago, I took a leap into the unknown, writes DONAL MACINTYRE. After tipping the scales the other way, here I reveal ...

As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

WEIGHT loss jabs could help control asthma symptoms in obese people, a study suggests – and it’s not just about losing weight ...